Leerink Partners Enhances Institutional Sales Team with Addition of Craig Roder
"We are thrilled to announce Craig's addition to the Institutional Sales team, reinforcing our commitment to delivering exceptional outcomes for our clients," said
"I am excited to join Leerink Partners' highly acclaimed Institutional Sales team. I look forward to leveraging my two decades of experience to offer the firm's clients insightful perspectives and analysis, helping them to achieve their investment objectives." said Roder.
Leerink Partners' Institutional Sales team delivers first-class knowledge and distribution platforms to assist clients in executing their strategies and achieving their goals. With a commitment to excellence, the team provides unparalleled insights, ensuring our clients stay ahead in the dynamic financial landscape. To learn more, visit: https://www.leerink.com/.
About Leerink Partners
Leerink Partners is a highly specialized healthcare investment bank with a legacy of excellence in the financial industry. The firm's experienced team delivers innovative advisory solutions, capital raising expertise, and unique insights to empower clients to achieve their strategic objectives. Since inception, the firm has helped clients raise over
Leerink Partners
Contact:
(617) 918-4097
Prosek Partners for Leerink Partners
Contact:
(646) 818-9251
View original content:https://www.prnewswire.com/news-releases/leerink-partners-enhances-institutional-sales-team-with-addition-of-craig-roder-301988544.html
SOURCE Leerink Partners
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corgi Insurance hires former Chubb Underwriting AVP James Kullman
- Adrenocortical Carcinoma Market is Projected to Grow by 2036 Owing to the Development of Novel Therapies | DelveInsight
- Solana Price Prediction: $150 SOL or a New 100x Entry? AlphaPepe Eyes Binance With $3.01M Raised
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share